Literature DB >> 25772946

New insights into the neurobiological mechanisms of major depressive disorders.

Marc Fakhoury1.   

Abstract

OBJECTIVE: To review the current evidence about the neurobiological mechanisms in major depressive disorders (MDD) and the key findings from studies using neuroimaging tools and animal models.
METHOD: This paper gives an overview of the role of genetic and environmental factors in the pathophysiology of MDD and describes the structural changes in brain structures of depressed individuals. A closer look is given at the molecular processes and neurotransmitters implicated in this mental disorder. Moreover, this paper discusses key findings from recent research using animal models and their relevance for clinical applications.
RESULTS: Although the exact cause of MDD is not known, there is enough evidence showing that genetic, psychological and environmental factors significantly increase the risk of developing this disease. Individuals affected by MDD exhibit a reduced volume of structures such as the amygdala, hippocampus and basal ganglia, as well as altered level of neurotransmitters in the brain.
CONCLUSION: The studies presented in this review show promising results that could shed light on the molecular mechanisms of MDD. However, more work needs to be done to better understand this psychiatric disorder and promote the development of new treatment strategies. Crown
Copyright © 2015. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antidepressant drug; Major depressive disorder; Neurobiology; Neurotransmitter

Mesh:

Year:  2015        PMID: 25772946     DOI: 10.1016/j.genhosppsych.2015.01.005

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  12 in total

Review 1.  Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.

Authors:  Marc Fakhoury
Journal:  Mol Neurobiol       Date:  2015-04-01       Impact factor: 5.590

2.  Machine learning model for predicting Major Depressive Disorder using RNA-Seq data: optimization of classification approach.

Authors:  Pragya Verma; Madhvi Shakya
Journal:  Cogn Neurodyn       Date:  2021-09-22       Impact factor: 5.082

3.  Low left amygdala volume is associated with a longer duration of unipolar depression.

Authors:  Maxim Zavorotnyy; Rebecca Zöllner; L R Schulte-Güstenberg; L Wulff; S Schöning; U Dannlowski; H Kugel; V Arolt; C Konrad
Journal:  J Neural Transm (Vienna)       Date:  2017-11-20       Impact factor: 3.575

4.  Antidepressant Effect and Modulation of the Redox System Mediated by Tannic Acid on Lipopolysaccharide-Induced Depressive and Inflammatory Changes in Mice.

Authors:  Karina Pereira Luduvico; Luiza Spohr; Mayara Sandrielly Pereira Soares; Fernanda Cardoso Teixeira; Alana Seixas de Farias; Natália Pontes Bona; Nathalia Stark Pedra; Anelize de Oliveira Campello Felix; Roselia Maria Spanevello; Francieli Moro Stefanello
Journal:  Neurochem Res       Date:  2020-06-05       Impact factor: 4.414

5.  A global assessment of the gender gap in self-reported health with survey data from 59 countries.

Authors:  Ties Boerma; Ahmad Reza Hosseinpoor; Emese Verdes; Somnath Chatterji
Journal:  BMC Public Health       Date:  2016-07-30       Impact factor: 3.295

6.  Microstructural Abnormalities of Basal Ganglia and Thalamus in Bipolar and Unipolar Disorders: A Diffusion Kurtosis and Perfusion Imaging Study.

Authors:  Lianping Zhao; Ying Wang; Yanbin Jia; Shuming Zhong; Yao Sun; Zhifeng Zhou; Zhongping Zhang; Li Huang
Journal:  Psychiatry Investig       Date:  2017-07-11       Impact factor: 2.505

7.  Why Your Body Can Jog Your Mind.

Authors:  Manuela Macedonia; Claudia Repetto
Journal:  Front Psychol       Date:  2017-03-09

8.  Gender differences in subtypes of depression by first incidence and age of onset: a follow-up of the Lundby population.

Authors:  Mats Bogren; L Brådvik; C Holmstrand; L Nöbbelin; C Mattisson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-18       Impact factor: 5.270

9.  Transcriptomics and sequencing analysis of gene expression profiling for major depressive disorder.

Authors:  Pragya Verma; Madhvi Shakya
Journal:  Indian J Psychiatry       Date:  2021-12-03       Impact factor: 1.759

Review 10.  Brexpiprazole for the Treatment of Schizophrenia and Major Depressive Disorder: A Comprehensive Review of Pharmacological Considerations in Clinical Practice.

Authors:  Amber N Edinoff; Natalie W Wu; Benjamin S Maxey; Amy L Ren; Kenna N Leethy; Brook Girma; Amira Odisho; Jessica S Kaye; Aaron J Kaye; Adam M Kaye; Alan D Kaye; George Mychaskiw; Omar Viswanath; Ivan Urits
Journal:  Psychopharmacol Bull       Date:  2021-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.